Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies have suggested that expression of alanine-expanded PABPN1 can induce ER stress and the unfolded protein response (UPR) potentiator guanabenz was reported to reduce ER stress and ameliorate OPMD phenotypes in the A17.1 mouse model [46].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boyle, E. I., Weng, S., Gollub, J., Jin, H., Botstein, D., Cherry, J. M., & Sherlock, G. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth456 · Cited by 2,067 · cited 1×
“This has been done using overexpressed test (75) of clusterProfiler package (76) and genome wide annotation for Mouse (77) in R.”
MethodDavies, J. E., Sarkar, S., & Rubinsztein, D. C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi422 · Cited by 207
Lemay, J.-F., D'Amours, A., Lemieux, C., Lackner, D. H., St-Sauveur, V. G., Bähler, J., & Bachand, F. (2010) · Molecular Cell · doi:10.1016/j.molcel.2009.12.019 · Cited by 112 · cited 1×
“small nucleolar RNA (snoRNA) processing (11).”
Endoplasmic reticulum stress in human skeletal muscle: any contribution to sarcopenia?
Deldicque, L. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00236 · Cited by 91
ER stress causes widespread protein aggregation and prion formation
Hamdan, N., Kritsiligkou, P., & Grant, C. M. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201612165 · Cited by 85 · cited 1×
“For example it is possible that unresolved ER stress generates more substrates for the UPS that would consequently lead to the overwhelming and saturation of the UPS degradation machinery in a self-reinforcing pathological cycle (64).”
Background
Research works printed but not linked: 71
- Abu-Baker, 2007, Oculopharyngeal muscular dystrophy: recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies, Biochim. Biophys. Acta, 1772, 173, 10.1016/j.bbadis.2006.10.003 · DOI
- Brais, 1998, Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy, Nat. Genet., 18, 164, 10.1038/ng0298-164 · DOI · Paper page
- Apponi, 2010, Loss of nuclear poly(A)-binding protein 1 causes defects in myogenesis and mRNA biogenesis, Hum. Mol. Genet., 19, 1058, 10.1093/hmg/ddp569 · DOI · Paper page
- Benoit, 2005, An essential cytoplasmic function for the nuclear poly(A) binding protein, PABP2, in poly(A) tail length control and early development in Drosophila, Dev. Cell, 9, 511, 10.1016/j.devcel.2005.09.002 · DOI
- Jenal, 2012, The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites, Cell, 149, 538, 10.1016/j.cell.2012.03.022 · DOI · Paper page
- Klerk, 2012, Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation, Nucleic Acids Res., 40, 9089, 10.1093/nar/gks655 · DOI · Paper page
- Bergeron, 2015, Regulated intron retention and nuclear pre-mRNA decay contribute to PABPN1 autoregulation, Mol. Cell. Biol., 35, 2503, 10.1128/MCB.00070-15 · DOI
- Muniz, 2015, Poly(A) polymerase and the nuclear poly(A) binding protein, PABPN1, coordinate the splicing and degradation of a subset of human pre-mRNAs, Mol. Cell. Biol., 35, 2218, 10.1128/MCB.00123-15 · DOI
- Beaulieu, 2012, Polyadenylation-dependent control of long noncoding RNA expression by the poly(A)- binding protein nuclear 1, PLoS Genet., 8, 10.1371/journal.pgen.1003078 · DOI · Paper page
- Bresson, 2013, The human nuclear poly(A)- binding protein promotes RNA hyperadenylation and decay, PLoS Genet., 9, 10.1371/journal.pgen.1003893 · DOI · Paper page
- Banerjee, 2017, Nuclear poly(A) binding protein 1 (PABPN1) and Matrin3 interact in muscle cells and regulate RNA processing, Nucleic Acids Res., 45, 10706, 10.1093/nar/gkx786 · DOI · Paper page
- Apponi, 2013, Control of mRNA stability contributes to low levels of nuclear poly(A) binding protein 1 (PABPN1) in skeletal muscle, Skelet. Muscle, 3, 23, 10.1186/2044-5040-3-23 · DOI · Paper page
- Gidaro, 2013, Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients, J. Neuropathol. Exp. Neurol., 72, 234, 10.1097/NEN.0b013e3182854c07 · DOI
- Tomé, 1980, Nuclear inclusions in oculopharyngeal dystrophy, Acta Neuropathol. (Berl.), 49, 85, 10.1007/BF00692226 · DOI
- Anvar, 2013, A decline in PABPN1 induces progressive muscle weakness in oculopharyngeal muscle dystrophy and in muscle aging, Aging, 5, 412, 10.18632/aging.100567 · DOI
- Malerba, 2017, PABPN1 gene therapy for oculopharyngeal muscular dystrophy, Nat. Commun., 8, 14848, 10.1038/ncomms14848 · DOI · Paper page
- Vest, 2017, Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology, Hum. Mol. Genet., 26, 3235, 10.1093/hmg/ddx206 · DOI · Paper page
- Blumen, 1999, Homozygotes for oculopharyngeal muscular dystrophy have a severe form of the disease, Ann. Neurol., 46, 115, 10.1002/1531-8249(199907)46:1<115::AID-ANA17>3.0.CO;2-O · doi:10.1002/1531-8249(199907)46:1<115::aid-ana17>3.0.co;2-o
- Abu-Baker, 2013, Lithium chloride attenuates cell death in oculopharyngeal muscular dystrophy by perturbing Wnt/β-catenin pathway, Cell Death Dis., 4, e821, 10.1038/cddis.2013.342 · DOI
- Bao, 2002, Mammalian, yeast, bacterial, and chemical chaperones reduce aggregate formation and death in a cell model of oculopharyngeal muscular dystrophy, J. Biol. Chem., 277, 12263, 10.1074/jbc.M109633200 · DOI · Paper page
- Bao, 2004, Congo red, doxycycline, and HSP70 overexpression reduce aggregate formation and cell death in cell models of oculopharyngeal muscular dystrophy, J. Med. Genet., 41, 47, 10.1136/jmg.2003.014548 · DOI
- Barbezier, 2011, Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy, EMBO Mol. Med., 3, 35, 10.1002/emmm.201000109 · DOI
- Davies, 2005, Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice, Nat. Med., 11, 672, 10.1038/nm1242 · DOI · Paper page
- Anvar, 2011, Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients, Skelet. Muscle, 1, 10.1186/2044-5040-1-15 · DOI
- Davies, 2010, Cystamine suppresses polyalanine toxicity in a mouse model of oculopharyngeal muscular dystrophy, Sci. Transl. Med., 2, 34ra40, 10.1126/scitranslmed.3000723 · DOI
- Périé, 2014, Autologous myoblast transplantation for oculopharyngeal muscular dystrophy: a phase I/IIa clinical study, Mol. Ther., 22, 219, 10.1038/mt.2013.155 · DOI
- Argov, 2016, Intravenous trehalose improves dysphagia and muscle function in oculopharyngeal muscular dystrophy (OPMD): preliminary results of 24 weeks open label phase 2 trial (I4.007), Neurology, 86, I4.007, 10.1212/WNL.86.16_supplement.I4.007 · doi:10.1212/wnl.86.16_supplement.i4.007
- Nash, 1973, Clinical trial with guanabenz, a new antihypertensive agent, J. Clin. Pharmacol., 13, 416
- Tribouillard-Tanvier, 2008, Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions, PloS One, 3, e1981, 10.1371/journal.pone.0001981 · doi:10.1371/journal.pone.0001981
- Blondel, 2016, Protein folding activity of the ribosome is involved in yeast prion propagation, Sci. Rep., 6, 32117, 10.1038/srep32117 · DOI
- Nguyen, 2014, Structure-activity relationship study around guanabenz identifies two derivatives retaining antiprion activity but having lost α2-adrenergic receptor agonistic activity, ACS Chem. Neurosci., 5, 1075, 10.1021/cn5001588 · DOI
- Reis, 2011, Mode of action of the antiprion drugs 6AP and GA on ribosome assisted protein folding, Biochimie, 93, 1047, 10.1016/j.biochi.2011.03.002 · doi:10.1016/j.biochi.2011.03.002
- Vieira, 2015, Guanabenz treatment accelerates disease in a mutant SOD1 mouse model of ALS, PloS One, 10, e0135570, 10.1371/journal.pone.0135570 · DOI
- Wang, 2014, Guanabenz, which enhances the unfolded protein response, ameliorates mutant SOD1-induced amyotrophic lateral sclerosis, Neurobiol. Dis., 71, 317, 10.1016/j.nbd.2014.08.010 · DOI · Paper page
- Tsaytler, 2011, Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis, Science, 332, 91, 10.1126/science.1201396 · DOI · Paper page
- Carrara, 2017, Decoding the selectivity of eIF2α holophosphatases and PPP1R15A inhibitors, Nat. Struct. Mol. Biol., 24, 708, 10.1038/nsmb.3443 · DOI · Paper page
- Das, 2015, Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit, Science, 348, 239, 10.1126/science.aaa4484 · DOI · Paper page
- Choy, 2015, Structural and functional analysis of the GADD34:PP1 eIF2α phosphatase, Cell Rep., 11, 1885, 10.1016/j.celrep.2015.05.043 · DOI · Paper page
- Crespillo-Casado, 2017, PPP1R15A-mediated dephosphorylation of eIF2α is unaffected by Sephin1 or guanabenz, Elife, 6, 10.7554/eLife.26109 · DOI · Paper page
- Crespillo-Casado, 2018, A Sephin1-insensitive tripartite holophosphatase dephosphorylates translation initiation factor 2α, J. Biol. Chem., 293, 7766, 10.1074/jbc.RA118.002325 · DOI
- Klein, 2016, Nuclear poly(A)-binding protein aggregates misplace a pre-mRNA outside of SC35 speckle causing its abnormal splicing, Nucleic Acids Res., 10.1093/nar/gkw703 · DOI · Paper page
- Raz, 2011, Modeling oculopharyngeal muscular dystrophy in myotube cultures reveals reduced accumulation of soluble mutant PABPN1 protein, Am. J. Pathol., 179, 1988, 10.1016/j.ajpath.2011.06.044 · DOI · Paper page
- Neuber, 2014, Guanabenz interferes with ER stress and exerts protective effects in cardiac myocytes, PLoS One, 9, e98893, 10.1371/journal.pone.0098893 · DOI
- Akiyama, 2009, Increased insulin demand promotes while pioglitazone prevents pancreatic beta cell apoptosis in Wfs1 knockout mice, Diabetologia, 52, 653, 10.1007/s00125-009-1270-6 · DOI
- Riggs, 2005, Mice conditionally lacking the Wolfram gene in pancreatic islet beta cells exhibit diabetes as a result of enhanced endoplasmic reticulum stress and apoptosis, Diabetologia, 48, 2313, 10.1007/s00125-005-1947-4 · DOI · Paper page
- Weidler, 1984, Dose-response relationship of single oral doses of guanabenz in hypertensive patients, J. Cardiovasc. Pharmacol., 6, S762, 10.1097/00005344-198400065-00007 · doi:10.1097/00005344-198400065-00007
- Walker, 1981, Long-term therapy of hypertension with guanabenz, Clin. Ther., 4, 217
- Trollet, 2010, Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres, Hum. Mol. Genet., 19, 2191, 10.1093/hmg/ddq098 · DOI
- Lindholm, 2017, Recent insights into the role of unfolded protein response in ER stress in health and disease, Front. Cell Dev. Biol., 5, 48, 10.3389/fcell.2017.00048 · DOI · Paper page
- Reyes, 1981, Intracellular spiral inclusions in cerebral cell processes in Creutzfeldt–Jakob disease, J. Neuropathol. Exp. Neurol., 40, 1, 10.1097/00005072-198101000-00001 · doi:10.1097/00005072-198101000-00001
- Tanaka, 2000, Immunohistochemical studies of the PrP(CJD) deposition in Creutzfeldt–Jakob disease, Neuropathology, 20, 124, 10.1046/j.1440-1789.2000.00285.x · DOI
- Tsuru, 2016, Novel mechanism of enhancing IRE1α-XBP1 signalling via the PERK-ATF4 pathway, Sci. Rep., 6, 24217, 10.1038/srep24217 · DOI
- Byrd, 2012, MicroRNA-30c-2* limits expression of proadaptive factor XBP1 in the unfolded protein response, J. Cell Biol., 196, 689, 10.1083/jcb.201201077 · DOI · Paper page
- Chhabra, 2011, Gene expression profiling indicate role of ER stress in miR-23a~27a~24-2 cluster induced apoptosis in HEK293T cells, RNA Biol., 8, 648, 10.4161/rna.8.4.15583 · DOI · Paper page
- Chartier, 2006, A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1, EMBO J., 25, 2253, 10.1038/sj.emboj.7601117 · DOI · Paper page
- Chartier, 2015, Mitochondrial dysfunction reveals the role of mRNA poly(A) tail regulation in oculopharyngeal muscular dystrophy pathogenesis, PLoS Genet., 11, 10.1371/journal.pgen.1005092 · DOI
- Brown, 2012, The endoplasmic reticulum stress response in aging and age-related diseases, Front. Physiol., 3, 263, 10.3389/fphys.2012.00263 · DOI · Paper page
- Fritz, 2014, Deficiency of the BiP cochaperone ERdj4 causes constitutive endoplasmic reticulum stress and metabolic defects, Mol. Biol. Cell, 25, 431, 10.1091/mbc.e13-06-0319 · DOI
- Harding, 2003, An integrated stress response regulates amino acid metabolism and resistance to oxidative stress, Mol. Cell, 11, 619, 10.1016/S1097-2765(03)00105-9 · DOI · Paper page
- Jiang, 2014, Nutrient deprivation induces α-synuclein aggregation through endoplasmic reticulum stress response and SREBP2 pathway, Front. Aging Neurosci., 6, 268, 10.3389/fnagi.2014.00268 · DOI
- Krebs, 2015, Ca(2+) homeostasis and endoplasmic reticulum (ER) stress: an integrated view of calcium signaling, Biochem. Biophys. Res. Commun., 460, 114, 10.1016/j.bbrc.2015.02.004 · DOI · Paper page
- Corbeil-Girard, 2005, PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions, Neurobiol. Dis., 18, 551, 10.1016/j.nbd.2004.10.019 · DOI
- Tavanez, 2009, Hsp70 chaperones and type I PRMTs are sequestered at intranuclear inclusions caused by polyalanine expansions in PABPN1, PLoS One, 4, 10.1371/journal.pone.0006418 · DOI
- García-Castañeda, 2017, Functional impact of an oculopharyngeal muscular dystrophy mutation in PABPN1, J. Physiol., 595, 4167, 10.1113/JP273948 · DOI
- Bahar, 2016, ER stress-mediated signaling: action potential and Ca(2+) as key players, Int. J. Mol. Sci., 17, 10.3390/ijms17091558 · DOI · Paper page
- Pinton, 2008, Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis, Oncogene, 27, 6407, 10.1038/onc.2008.308 · DOI · Paper page
- Lee, 2002, IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response, Genes Dev., 16, 452, 10.1101/gad.964702 · DOI · Paper page
- Morgan, 1994, Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines, Dev. Biol., 162, 486, 10.1006/dbio.1994.1103 · DOI · Paper page
- Holmes, 1983, Guanabenz. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension, Drugs, 26, 212, 10.2165/00003495-198326030-00003 · DOI
- Malerba, 2011, Chronic systemic therapy with low-dose morpholino oligomers ameliorates the pathology and normalizes locomotor behavior in mdx mice, Mol. Ther., 19, 345, 10.1038/mt.2010.261 · DOI
- Yu, 2012, clusterProfiler: an R package for comparing biological themes among gene clusters, OMICS, 16, 284, 10.1089/omi.2011.0118 · DOI · Paper page
Cited by
Mezzell, A. T., Zhang, Y., Perez, A. M., & Vest, K. E. (2026) · PLOS Genetics · doi:10.1371/journal.pgen.1011743 · Cited by 7
Metadata
- Authors
- Malerba, A., Roth, F., Harish, P., Dhiab, J., Lu-Nguyen, N., Cappellari, O., Jarmin, S., Mahoudeau, A., Ythier, V., Lainé, J., Negroni, E., Abgueguen, E., Simonelig, M., Guedat, P., Mouly, V., Butler-Browne, G., Voisset, C., Dickson, G., & Trollet, C.
- Affiliations
- School of Biological Sciences, Centers of Gene and Cell Therapy and Biomedical Sciences, Royal Holloway, University of London, TW20 OEX Surrey, UK
- Sorbonne Université, INSERM, Association Institut de Myologie, Centre de Recherche en Myologie, UMRS974, 47 bd de l’Hôpital, Paris, France
- Comparative Biomedical Sciences, The Royal Veterinary College, London, UK
- Inflectis Bioscience, Nantes, France
- Institute of Human Genetics, CNRS UMR9002-University of Montpellier, mRNA Regulation and Development, Montpellier, France
- UMR1078 ‘Genetic, Functional Genomic and Biotechnologies’, INSERM, EFS, Brest University, IBSAM, Brest, France
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-01-14
- Volume
- 28
- Issue
- 10
- Pages
- 1694-1708
- ISSN
- 0964-6906
- 1460-2083
- Cited by
- 33
- References
- 5
- Language
- en
- Funders
- Centre National de la Recherche Scientifique
- Association Française contre les Myopathies (17110)
- Sorbonne University association
- Institut National de la Santé et de la Recherche Médicale
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy. https://app.cochat.ai/papers/10.1093/hmg/ddz007
- The paper
- Malerba, A., Roth, F., Harish, P., Dhiab, J., Lu-Nguyen, N., Cappellari, O., Jarmin, S., Mahoudeau, A., Ythier, V., Lainé, J., Negroni, E., Abgueguen, E., Simonelig, M., Guedat, P., Mouly, V., Butler-Browne, G., Voisset, C., Dickson, G., & Trollet, C. (2019). Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddz007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.